Molecular tumour board review
Authoring and signing every Blueprint Care decision.
Company · our exclusive clinical partner
KPCIRC
Where OnKommon was born, and the licensed clinical authority behind everything we deliver.
01Who KPCIRC is
Our exclusive clinical partner
KPCIRC, the Kwatra Precision Cancer Institute and Research Centre, is where OnKommon was born and the licensed clinical authority behind everything we deliver.
02
What KPCIRC delivers
Second opinions
Independent clinical review on a paid basis, whenever you want one.
Genetic counselling
Before and after inherited-risk testing.
Patient navigation
The human coordination that carries a plan into action.
Oversight of monitoring
Acting on Sentinel and Clear findings as they arrive.
03
Exclusive by design
Not a marketplace of interchangeable labs and signatories.
OnKommon and KPCIRC are exclusive to each other. One accountable clinical partner whose judgement stands behind every report. That exclusivity is what lets us promise a named, consistent standard of care across the whole ecosystem.
04
The clean answer on accountability
Every patient and every doctor asks the same two questions of any precision-oncology service: who is clinically responsible, and is a machine making the decision?
Who is responsible
A licensed clinical team at KPCIRC, named and accountable.
Is a machine deciding
No. Our technology informs them. They decide.
Take the next step
Three ways forward. Pick the one that fits today.
Book a free consultation
A no-obligation conversation with our care team, arranged through KPCIRC.
Book a consultationBegin Blueprint Care
Commission your decision report and a dedicated clinical team.
Explore Blueprint CareAsk on WhatsApp, free
Signal replies to your first question within four hours, at no cost.
Start with Signal